Riskpilot← Back to searchSign inGet full accessNordicus AB
ABActiveOrg 5591721310Kilängsgatan 3Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 106K
-80% vs 2024
EBITDA margin
-4.8%
-618% vs 2024
Equity ratio
74.6%
Financial strength
Net profit 2025
SEK -5K
-556% vs 2024
| Revenue | SEK 106K | -80% |
| EBITDA | SEK -5K | -618% |
| Net profit | SEK -5K | -556% |
| Total assets | SEK 72K | +2% |
| Equity | SEK 54K | -8% |
| Employees | 1 | — |
Legal name
Nordicus AB
Org number
5591721310
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 september 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget kommer att ta hyrläkare-uppdrag inom öppen- och slutenvård, inom endokrinologi och internmedicin.
Address
Kilängsgatan 3
Email
info@evangeloslolis.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 801 | 602 | 435 | 528 | 106 |
| Staff expenses | — | −562 | −177 | −427 | −15 |
| EBITDA | 440 | −108 | 54 | 1 | −5 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 440 | −108 | 54 | 1 | −5 |
| Net financials | — | −1 | −8 | 0 | 0 |
| Profit before tax | 331 | 70 | 46 | 1 | −5 |
| Tax | −69 | −15 | −12 | −0 | — |
| Net profit | 262 | 55 | 34 | 1 | −5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 708 | 526 | 155 | 70 | 72 |
| Equity | 349 | 261 | 107 | 59 | 54 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 180 | 265 | 47 | 12 | 18 |
| Total debt | 180 | 265 | 47 | 12 | 18 |
EBITDA margin
-4.8%
This company
15.8%
Market median
-130% vs market
20212025
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
-9.2%
This company
18.4%
Market median
-150% vs market
20212025
Net profit margin
-4.6%
This company
8.1%
Market median
-157% vs market
20212025
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordicus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sai Victor Bauder Fonturvel | Deputy Board Member | 0 companies |
| Evangelos Lolis | Board of Directors | 0 companies |
| Andriani Vellis | Deputy Board Member | 0 companies |
| Jens Viktor Lund Olsson | Deputy Board Member | 0 companies |